Unique ID issued by UMIN | UMIN000022511 |
---|---|
Receipt number | R000025950 |
Scientific Title | A study of repetitive transcranial magnetic stimulation for functional recovery of stroke patients |
Date of disclosure of the study information | 2016/06/01 |
Last modified on | 2019/06/01 18:36:03 |
A study of repetitive transcranial magnetic stimulation for functional recovery of stroke patients
A study of repetitive transcranial magnetic stimulation for functional recovery of stroke patients
A study of repetitive transcranial magnetic stimulation for functional recovery of stroke patients
A study of repetitive transcranial magnetic stimulation for functional recovery of stroke patients
Japan |
stroke
Medicine in general | Neurology | Adult |
Others
NO
functional recovery of hemiparetic stroke patients
Safety,Efficacy
Exploratory
Explanatory
Finger tapping speed, walking speed (3m Timed Up-and-go test)
FIM (Functional Independence Measure)
SIAS (Stroke Impairment Assessment Set)
Brunnstrom stage
Manual muscle testing
Finger pinch force
Interventional
Cross-over
Randomized
Individual
Single blind -participants are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
NO
Pseudo-randomization
2
Treatment
Device,equipment |
1Hz-repetitive transcranial magnetic stimulation (max. 2000 pulses/session; stimulus intensity, 90% resting motor threshold; target, primary motor cortex contralateral to the paretic side)
1 session/week, 4 weeks
Real stimualtion vs. placebo
Cross-over design
Stimulator; Magstim Rapid (The Magstim Company, UK)(Code; 36902000)
placebo (the stimulation coil is detached apart from the sculp or tilted 45-90 degrees to the tangential plane of the sculp)
18 | years-old | <= |
100 | years-old | >= |
Male and Female
1) chronic-stage hemiparetic stroke patient (6 months or more after onset)
2) written informed consent
3) outpatient
1) severe medical illness
2) permanent pacemaker, cerebral aneurysm clipping
3) epilepsy
4) consciousness disturbance, advanced dementia or communicative difficulties
5) any other conditions unsuitable to the study judged by doctor(s)
30
1st name | |
Middle name | |
Last name | Takayuki Katayama |
Asahikawa Medical University
First Department of Internal Medicine
2-1-1-1 Midorigaoka-Higashi, Asahikawa, Hokkaido
+81-(0)166-68-2442
katataka@asahikawa-med.ac.jp
1st name | |
Middle name | |
Last name | Takayuki Katayama |
Asahikawa Medical University
First Department of Internal Medicine
2-1-1-1 Midorigaoka-Higashi, Asahikawa, Hokkaido
+81-(0)166-68-2442
katataka@asahikawa-meda.c.jp
Ministry of Education, Culture, Sports, Science and Technology
Ministry of Education, Culture, Sports, Science and Technology
Japanese Governmental office
NO
2016 | Year | 06 | Month | 01 | Day |
Unpublished
Terminated
2016 | Year | 05 | Month | 29 | Day |
2016 | Year | 05 | Month | 27 | Day |
2016 | Year | 06 | Month | 01 | Day |
2019 | Year | 06 | Month | 01 | Day |
2019 | Year | 06 | Month | 01 | Day |
2019 | Year | 06 | Month | 01 | Day |
2019 | Year | 06 | Month | 01 | Day |
This study is terminated bacause
1) the patient number did not reach the target
and
2) the representative researcher will move to other institution
2016 | Year | 05 | Month | 29 | Day |
2019 | Year | 06 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025950